Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Dexedrine Adds Black Box On Cardiovascular Events

This article was originally published in The Pink Sheet Daily

Executive Summary

ADHD product also adds class warnings on psychiatric events, seizures and visual disturbance.
Advertisement

Related Content

Novartis’ Ritalin LA Faces Patent Challenge
Novartis’ Ritalin LA Faces Patent Challenge
Shire’s New ADHD Drug Coming Into Focus
Shire’s New ADHD Drug Coming Into Focus
Shire/Noven Daytrana Patch To Carry Similar Warnings To Other ADHD Drugs, FDA Says
ADHD Black Box Warning On Psychiatric/Cardiac Events Is Unnecessary, Pediatric Committee Says
ADHD Black Box Warning On Psychiatric/Cardiac Events Is Unnecessary, Pediatric Committee Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS064712

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel